期刊文献+

调控人骨髓间充质干细胞成骨分化的miR-106a及其靶基因骨形态发生受体蛋白2 被引量:2

miR-106a regulates the osteogenic differentiation of human bone marrow mesenchymal stem cells by targeting bone morphogenetic protein receptor 2
下载PDF
导出
摘要 背景:正常生理条件下,人骨髓间充质干细胞的骨生成和脂肪生成维持平衡,成骨分化是骨骼发展的重要过程,骨骼形成需要成骨细胞的分化和成熟。目的:探索mi R-106及其靶基因骨形态发生受体蛋白2在成骨分化中的作用,为后续研究奠定基础。方法:使用成骨诱导培养基诱导骨髓间充质干细胞分化为成骨细胞,通过Western blot和碱性磷酸酶染色检测成骨分化标志物表达情况判断成骨分化进程。通过转染模拟剂过表达miR-106a,转染si RNA敲降骨形态发生受体蛋白2的表达,分别使用Real-time PCR和Western blot检测miR-106a和骨形态发生受体蛋白2表达情况。TargetS can软件预测和双荧光素酶报告实验验证miR-106a和骨形态发生受体蛋白2的相互作用。结果与结论:在成骨分化过程中miR-106a表达下调,骨形态发生受体蛋白2表达上调。过表达miR-106a,结果发现碱性磷酸酶活性下降,成骨分化标志蛋白Runx2和OCN表达量下降,同时骨形态发生受体蛋白2表达下调。使用TargetS can预测骨形态发生受体蛋白2可能是mi R-106a的靶基因,双荧光素酶报告实验验证了预测结果。敲降骨形态发生受体蛋白2的表达,成骨分化受到抑制。结果表明miR-106a通过靶向骨形态发生受体蛋白2从而调控骨髓间充质干细胞向成骨细胞分化。 BACKGROUND:Under normal physiological conditions, there is a homeostasis between the osteogenic and adipogenic differentiation of human bone marrow mesenchymal stem cel s. Osteogenic differentiation is an important process in the formation of skeleton in which differentiated and mature osteoblasts are indispensable. OBJECTIVE:To explore the role of miR-106a and its target gene, bone morphogenetic protein receptor 2 (BMPR2) in the differentiation of human bone marrow mesenchymal stem cel s into osteoblasts. METHODS:Human bone marrow mesenchymal stem cel s were induced to differentiate into osteoblasts by osteoblast-specific induction medium, and this process was detected by western blot and alkaline phosphatase staining. Overexpression of miR-106a was elicited by transfecting miR-106a mimics and the BMPR2 knockdown achieved by RNA interference. The expression levels of miR-106a and BMPR2 were detected by real-time PCR and western blot, respectively. The interaction of miR-106a and BMPR2 was verified by TargetScan software and dual luciferase report experiment assay. RESULTS AND CONCLUSION:The expression of miR-106a was decreased whereas the expression of BMPR2 increased with the progress of osteogenesis differentiation. When miR-106a was overexpressed, alkaline phosphatase activity was declined and the expressions of runt-related transcription factor 2 and osteocalcin, markers of osteogenesis differentiation, both decreased. The expression of BMPR2 was decreased as wel . BMPR2 was predicted to be the target gene of miR-106a by TargetScan software and this prediction proved by dual luciferase report experiments assay. Additional y, osteogenesis differentiation was inhibited by knocking down the expression of BMPR2. These results indicate that miR-106a regulates the differentiation of bone marrow mesenchymal stem cel s into osteoblasts by targeting BMPR2.
作者 顾夙
出处 《中国组织工程研究》 CAS 北大核心 2016年第28期4109-4116,共8页 Chinese Journal of Tissue Engineering Research
  • 相关文献

参考文献42

  • 1Katagiri T, Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis. 2002;8(3): 147-159.
  • 2Nakashima K, de Crombrugghe B. Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet. 2003; 19(8):458-466.
  • 3Vimalraj S, Selvamurugan N. MicroRNAs: Synthesis, Gene Regulation and Osteoblast Differentiation. Curr Issues Mol Biol. 2013;15:7-18.
  • 4Sacchetti B, Funari A, Michienzi S, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell. 2007; 131 (2):324-336.
  • 5Vimalraj S, Selvamurugan N. MicroRNAs expression and their regulatory networks during mesenchymal stem cells differentiation toward osteoblasts. Int J Biol Macromol. 2014;66:194-202.
  • 6Wei J, Li H, Wang S, et al. let-7 enhances osteogenesis and bone formation while repressing adipogenesis of human stromal/mesenchymal stem cells by regulating HMGA2. Stem Cells Dev. 2014; 23(13): 1452-1463.
  • 7Lian JB, Stein GS, van Wijnen A J, et al. MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol. 2012;8(4):212-227.
  • 8Taipaleenmaki H, Bjerre Hokland L, Chen L, et al. Mechanisms in endocrinology: micro-RNAs: targets for enhancing osteoblast differentiation and bone formation. Eur J Endocrinol. 2012;166(3):359-371.
  • 9Thomas M, Lieberman J, Lal A. Desperately seeking microRNA targets. Nat Struct Mol Biol. 2010; 17(10): 1169-1174.
  • 10Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011 ;12(12):861-874.

二级参考文献83

  • 1中华人民共和国科学技术部.关于善待实验动物的指导性意见.2006.09-30
  • 2Chen ZX,Chang M,Peng YL,et al.Osteogenic growth peptide C-terminal pentapeptide[OGP(10-14)]acts on rat bone marrow mesenchyrnal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes.Regul Pept.2007;142(1-2):16-23.
  • 3Fu L,Tang T,Miao Y,et al.Stimulation of osteogenic differentiation and inhibition of adipogenic differentiation in bone marrow stromal cells by alendronate via ERK and JNK activation.Bone.2008;43(1):40-47.
  • 4Nakashima K,Zhou X,Kunkel G,et al.The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation.Cell.2002;108(1):17-29.
  • 5Nishimura R,Hata K,Ikeda F,et al.Signal transduction and transcriptional regulation during mesenchymal cell differentiation.J Bone Miner Metab.2008;26(3):203-212.
  • 6Kang JW,Choi Y,Park JH,et al.The effects of cyclin-dependent kinase inhibitors on adipogenic differentiation of human mesenchymal stem cells.Biochem Biophys Res Commun.2008;366(3):624-630.
  • 7Valenti MT,Dalle Carbonare L,Donatelli L,et al.Gene expression analysis in osteoblastic differentiation from peripheral blood mesenchymal stem cells.Bone.2008;43(6):1084-1092.
  • 8Igarashi M,Kamiya N,Hasegawa M,et al.Inductive effects of dexamethasone on the gene expression of Cbfal,Osterix and bone matrix proteins during differentiation of cultured primary rat osteoblasts.J Mol Histol.2004;35(1):3-10.
  • 9Muruganandan S,Roman AA,Sinai CJ.Adipocyte differentiation of bone marrow-derived mesenchymal stem cells:cross talk with the osteoblastogenic program.Cell Mol Life Sci.2009;66(2):236-253.
  • 10Pereira R C, Economides A N, Canalis E. Bone morphogenetic proteins induce gremlin, a protein that fimits their activity in osteoblasts. Endocrinology, 2000, 141: 4558-4563.

共引文献47

同被引文献60

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部